Why the study?
Does discharge from a hospital without PCI facilities reduce the rate of guideline-recommended secondary prevention interventions in patients with ACS compared to discharge from a PCI-capable hospital?
Does discharge from a hospital without PCI facilities reduce the rate of guideline-recommended secondary prevention interventions in patients with ACS compared to discharge from a PCI-capable hospital?
Patients with ACS transferred to non-PCI hospitals receive similar rates of secondary prevention medications at discharge compared to those remaining in PCI-capable hospitals, though smoking cessation counseling and cardiac rehab attendance differ.
No takes yet. Share an insight, caveat, or question.
Similar medication rates at non-PCI hospital discharge; leaves open whether PCI capability affects overall secondary prevention quality.
Welker et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: